Literature DB >> 12241008

Induction of differentiation in acute promyelocytic leukemia cells (HL-60) by the verticillin derivative Sch 52900.

Gerhard Erkel1, Alexandra Gehrt, Timm Anke, Olov Sterner.   

Abstract

The HL-60 cell line, derived from a patient with acute promyelocytic leukemia, is a widely used model system to study the cellular and molecular events involved in differentiation of leukemic cells. In a screening for inducers of differentiation of HL-60 cells, cultures of Gliocladium strain 4-93 were found to produce Sch 52900, a previously isolated diketopiperazine (Chu et al,. J Antibiotics 48, 1440-1445). Sch 52900 induced the differentation of 50-69% of HL-60 cells at concentrations of 6.8-13.6 nM as measured by nitro-blue tetrazolium chloride (NBT) reduction which was followed by apoptosis as shown by DNA fragmentation. Our results demonstrate that growth arrest and the induction of differentiation by Sch 52900 is due to the induction of the cell cycle inhibitor p21WAF and an inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway which leads to the activation of the transcription factor AP-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12241008     DOI: 10.1515/znc-2002-7-834

Source DB:  PubMed          Journal:  Z Naturforsch C J Biosci        ISSN: 0341-0382


  11 in total

1.  Cytotoxic epipolythiodioxopiperazine alkaloids from filamentous fungi of the Bionectriaceae.

Authors:  Mario Figueroa; Tyler N Graf; Sloan Ayers; Audrey F Adcock; David J Kroll; Jilai Yang; Steven M Swanson; Ulyana Munoz-Acuna; Esperanza J Carcache de Blanco; Rajesh Agrawal; Mansukh C Wani; Blaise A Darveaux; Cedric J Pearce; Nicholas H Oberlies
Journal:  J Antibiot (Tokyo)       Date:  2012-09-12       Impact factor: 2.649

2.  Lophocladines, bioactive alkaloids from the red alga Lophocladia sp.

Authors:  Harald Gross; Douglas E Goeger; Patrice Hills; Susan L Mooberry; David L Ballantine; Thomas F Murray; Frederick A Valeriote; William H Gerwick
Journal:  J Nat Prod       Date:  2006-04       Impact factor: 4.050

3.  LG-362B targets PML-RARα and blocks ATRA resistance of acute promyelocytic leukemia.

Authors:  X Wang; Q Lin; F Lv; N Liu; Y Xu; M Liu; Y Chen; Z Yi
Journal:  Leukemia       Date:  2016-03-08       Impact factor: 11.528

4.  Enantioselective total synthesis of (+)-gliocladine C: convergent construction of cyclotryptamine-fused polyoxopiperazines and a general approach for preparing epidithiodioxopiperazines from trioxopiperazine precursors.

Authors:  John E DeLorbe; Salman Y Jabri; Steven M Mennen; Larry E Overman; Fang-Li Zhang
Journal:  J Am Chem Soc       Date:  2011-04-07       Impact factor: 15.419

5.  Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress.

Authors:  Crescent R Isham; Jennifer D Tibodeau; Wendy Jin; Ruifang Xu; Michael M Timm; Keith C Bible
Journal:  Blood       Date:  2006-11-07       Impact factor: 22.113

6.  General approach for preparing epidithiodioxopiperazines from trioxopiperazine precursors: enantioselective total syntheses of (+)- and (-)-gliocladine C, (+)-leptosin D, (+)-T988C, (+)-bionectin A, and (+)-gliocladin A.

Authors:  John E DeLorbe; David Horne; Richard Jove; Steven M Mennen; Sangkil Nam; Fang-Li Zhang; Larry E Overman
Journal:  J Am Chem Soc       Date:  2013-03-01       Impact factor: 15.419

7.  Ecology-based screen identifies new metabolites from a Cordyceps-colonizing fungus as cancer cell proliferation inhibitors and apoptosis inducers.

Authors:  Y Chen; H Guo; Z Du; X-Z Liu; Y Che; X Ye
Journal:  Cell Prolif       Date:  2009-08-11       Impact factor: 6.831

8.  High-resolution MS, MS/MS, and UV database of fungal secondary metabolites as a dereplication protocol for bioactive natural products.

Authors:  Tamam El-Elimat; Mario Figueroa; Brandie M Ehrmann; Nadja B Cech; Cedric J Pearce; Nicholas H Oberlies
Journal:  J Nat Prod       Date:  2013-08-16       Impact factor: 4.050

9.  Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663.

Authors:  Pan Jian; Zhao Wen Li; Tao Yan Fang; Wang Jian; Zhou Zhuan; Liao Xin Mei; Wu Shui Yan; Ni Jian
Journal:  J Hematol Oncol       Date:  2011-04-25       Impact factor: 17.388

10.  ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer.

Authors:  Juliane Strietz; Stella S Stepputtis; Bogdan-Tiberius Preca; Corinne Vannier; Mihee M Kim; David J Castro; Qingyan Au; Melanie Boerries; Hauke Busch; Pedro Aza-Blanc; Susanne Heynen-Genel; Peter Bronsert; Bernhard Kuster; Elmar Stickeler; Thomas Brabletz; Robert G Oshima; Jochen Maurer
Journal:  Oncotarget       Date:  2016-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.